Gene Modifiers of Cystic Fibrosis Lung Disease
NCT00037765 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2025-09-23
Summary
The purpose of this study is to examine genetic modifiers of the severity of cystic fibrosis lung disease.
Conditions
- Cystic Fibrosis
- Lung Diseases
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
University of North Carolina, Chapel Hill
lead OTHER
Principal Investigators
-
Wanda K O'Neal, PhD · University of North Carolina
Eligibility
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-09-30
- Primary Completion
- 2027-07-31
- Completion
- 2027-07-31
Countries
- United States
Study Locations
More Related Trials
-
Genetic Modifiers of Cystic Fibrosis Related Diabetes
NCT01113216 ·Status: ENROLLING_BY_INVITATION
-
Costimulatory Molecules as Biomarkers in Cystic Fibrosis
NCT01353950 ·Status: COMPLETED
-
Diagnosis and Treatment of Patients With Cystic Fibrosis
NCT00001223 ·Status: TERMINATED
-
Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies
NCT00727285 ·Status: COMPLETED
-
Viral Pathogenesis of Early Cystic Fibrosis Lung Disease
NCT01973192 ·Status: COMPLETED
-
Biomarkers of Injury and Destruction in the Cystic Fibrosis Lung
NCT01805713 ·Status: COMPLETED
-
A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Disease
NCT00311506 ·Status: COMPLETED
-
Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis
NCT06188988 ·Status: ENROLLING_BY_INVITATION
-
Nutrition Supplement for Cystic Fibrosis
NCT07163078 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Early Intervention in Cystic Fibrosis Exacerbation
NCT01104402 ·Status: COMPLETED ·Phase: NA
-
Evaluating Sensations of Breathlessness in Patients With Cystic Fibrosis
NCT01799642 ·Status: COMPLETED
-
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
NCT06296394 ·Status: RECRUITING
-
Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis
NCT01661491 ·Status: COMPLETED
-
Evaluating the Impact of Chronic Rhinosinusitis on the Health-Related Quality of Life Among Adults With Cystic Fibrosis
NCT02003079 ·Status: COMPLETED
-
Asthma With Hypersecretion-associated Gene for Cystic Fibrosis
NCT02558127 ·Status: COMPLETED
-
Determinants of Early Cystic Fibrosis Lung Disease
NCT03579173 ·Status: COMPLETED
-
Physical Activity Profile and Sedentary Behaviour in Adults With Cystic Fibrosis
NCT06507956 ·Status: RECRUITING
-
Assessment of Fat Free Mass Index and Its Impact on Health in Children With Cystic Fibrosis
NCT01401439 ·Status: COMPLETED
-
The Relationship Between CFTR Gene Mutations and Exercise Capacity
NCT05157646 ·Status: WITHDRAWN ·Phase: NA
-
Small Circulating RNA as Molecular Markers of Lung Disease in Cystic Fibrosis
NCT02992080 ·Status: COMPLETED ·Phase: NA
-
Health Outcomes of Parents With Cystic Fibrosis
NCT05829694 ·Status: COMPLETED
-
Pulmonary Vascular Disease in CF
NCT04549077 ·Status: ACTIVE_NOT_RECRUITING
-
Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene, in Patients With Cystic Fibrosis
NCT00004779 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability and Pharmacokinetics Study of FDL169 in Healthy Subjects and Subjects With Cystic Fibrosis
NCT02767297 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis
NCT00004806 ·Status: COMPLETED ·Phase: PHASE1